NEW YORK (Reuters) - U.S. biopharmaceutical company Genta Inc GNTA.O said on Monday that it received a notice from Nasdaq saying its shares did not comply with listing rules, which require a minimum closing bid price of $1.00.
Genta shares earlier fell 4 cents, or 6.15 percent, to 61 cents. The company said it has until June 16, 2008, to regain compliance.
(Reporting by Ritsuko Ando, editing by Leslie Gevirtz)
© Thomson Reuters 2008 All rights reserved
A selection of our best photos from the past 24 hours. View Slideshow
Asia greets G7 weekend pledges
Brown: Government must be rock in UK
Deadly blasts rock Baghdad
Australian shares up by six percent
Brown seeks new financial order
Japan's latest robots
Space tourist blasts off
Facebook eyes growth over profits
Australia guarantees deposits
Russia tests long-range missile
Reuters.com:
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Interactive TV |
Labs |
Reuters in Second Life |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Tech Week
